관절통 주사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Joint Pain Injections Market size is expected to reach USD 16.68 Billion in 2034 from USD 6.80 Billion (2025) growing at a CAGR of 10.49% during 2026-2034.

The global joint pain injections market has grown steadily due to rising cases of arthritis and joint disorders. Aging populations and lifestyle-related conditions have increased demand for pain management treatments. Injections such as corticosteroids and hyaluronic acid provide relief without major surgery, supporting market growth.

Major drivers include increasing awareness about minimally invasive treatments. Growing healthcare spending and improved access to orthopedic care further boost demand. Technological advancements in injection techniques have improved safety and effectiveness. Expanding outpatient care centers also support market expansion.

In the future, the market is expected to grow with the development of regenerative therapies and biologic injections. However, high treatment costs and possible side effects may limit adoption. Overall, increasing focus on mobility and quality of life will sustain demand.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type of Injection

• Steroid Joint Injection
• Hyaluronic Acid Injections
• Platelet-Rich Plasma (PRP) Injections
• Placental Tissue Matrix (PTM) Injections
• Other Types of Injections

By Joint Type

• Hip Joint
• Knee And Ankle
• Shoulder And Elbow
• Facet Joints Of The Spine
• Other Joint Types

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

COMPANIES PROFILED

• Seikagaku Corporation, Flexion Therapeutics Inc, Zimmer Biomet Holdings Inc, Sanofi SA, Anika Therapeutics Inc, AbbVie Inc, Bioventus LLC, Eli Lilly and Company, Ferring Pharmaceuticals Inc, Pfizer Inc, Teva Pharmaceutical Industries Limited, Johnson Johnson Services Inc, Merck Co Inc, GlaxoSmithKline plc, Novartis AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL JOINT PAIN INJECTIONS MARKET: BY TYPE OF INJECTION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type Of Injection
• 4.2. Steroid Joint Injection Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Hyaluronic Acid Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Platelet-Rich Plasma (PRP) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Placental Tissue Matrix (PTM) Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Types of Injections Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL JOINT PAIN INJECTIONS MARKET: BY JOINT TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Joint Type
• 5.2. Hip Joint Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Knee And Ankle Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Shoulder And Elbow Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Facet Joints Of The Spine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Joint Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL JOINT PAIN INJECTIONS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. Hospital Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Retail Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Online Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL JOINT PAIN INJECTIONS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Type Of Injection
  • 7.2.2 By Joint Type
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Type Of Injection
  • 7.3.2 By Joint Type
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Type Of Injection
  • 7.4.2 By Joint Type
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Type Of Injection
  • 7.5.2 By Joint Type
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Type Of Injection
  • 7.6.2 By Joint Type
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL JOINT PAIN INJECTIONS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Seikagaku Corporation
  • 9.2.2 Flexion Therapeutics Inc
  • 9.2.3 Zimmer Biomet Holdings Inc
  • 9.2.4 Sanofi S.A
  • 9.2.5 Anika Therapeutics Inc
  • 9.2.6 AbbVie Inc
  • 9.2.7 Bioventus LLC
  • 9.2.8 Eli Lilly And Company
  • 9.2.9 Ferring Pharmaceuticals Inc
  • 9.2.10 Pfizer Inc
  • 9.2.11 Teva Pharmaceutical Industries Limited
  • 9.2.12 Johnson & Johnson Services Inc
  • 9.2.13 Merck & Co. Inc
  • 9.2.14 GlaxoSmithKline Plc
  • 9.2.15 Novartis AG